The mode of sensitization and its influence on allograft outcomes in highly sensitized kidney transplant recipients

被引:64
|
作者
Redfield, Robert R. [1 ]
Scalea, Joseph R. [1 ]
Zens, Tiffany J. [1 ]
Mandelbrot, Didier A. [2 ]
Leverson, Glen [1 ]
Kaufman, Dixon B. [1 ]
Djamali, Arjang [1 ,2 ]
机构
[1] Univ Wisconsin Hosp & Clin, Div Transplant Surg, Madison, WI 53792 USA
[2] Univ Wisconsin Hosp & Clin, Dept Med, Div Nephrol, Madison, WI 53792 USA
关键词
graft survival; kidney transplantation; ANTIBODY-MEDIATED REJECTION; CYTOMETRY CROSS-MATCH; RENAL-TRANSPLANTATION; IMPACT; TRANSFUSIONS; SURVIVAL; TERM;
D O I
10.1093/ndt/gfw099
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
We sought to determine whether the mode of sensitization in highly sensitized patients contributed to kidney allograft survival. An analysis of the United Network for Organ Sharing dataset involving all kidney transplants between 1997 and 2014 was undertaken. Highly sensitized adult kidney transplant recipients [panel reactive antibody (PRA) a parts per thousand yen98%] were compared with adult, primary non-sensitized and re-transplant recipients. Kaplan-Meier survival analyses were used to determine allograft survival rates. Cox proportional hazards regression analyses were conducted to determine the association of graft loss with key predictors. Fifty-three percent of highly sensitized patients transplanted were re-transplants. Pregnancy and transfusion were the only sensitizing event in 20 and 5%, respectively. The 10-year actuarial graft survival for highly sensitized recipients was 43.9% compared with 52.4% for non-sensitized patients, P < 0.001. The combination of being highly sensitized by either pregnancy or blood transfusion increased the risk of graft loss by 23% [hazard ratio (HR) 1.230, confidence interval (CI) 1.150-1.315, P < 0.001], and the combination of being highly sensitized from a prior transplant increased the risk of graft loss by 58.1% (HR 1.581, CI 1.473-1.698, P < 0.001). The mode of sensitization predicts graft survival in highly sensitized kidney transplant recipients (PRA a parts per thousand yen98%). Patients who are highly sensitized from re-transplants have inferior graft survival compared with patients who are highly sensitized from other modes of sensitization.
引用
收藏
页码:1746 / 1753
页数:8
相关论文
共 50 条
  • [21] Rituximab induction therapy in highly sensitized kidney transplant recipients
    YIN HangWAN HaoHU XiaopengLI XiaobeiWANG WeiLIU HangREN Liang and ZHANG Xiaodong Kidney Transplantation ProgramDepartment of UrologyBeijing ChaoYang HospitalCapital Medical UniversityBeijing China
    中华医学杂志(英文版), 2011, (13) : 1928 - 1932
  • [22] Algorithm to Manage Highly Sensitized Kidney Transplant Recipients in Poland
    Zielinska, H.
    Moszkowska, G.
    Zielinski, M.
    Debska-Slizien, A.
    Rutkowski, B.
    Trzonkowski, P.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (08) : 2903 - 2907
  • [23] Rituximab induction therapy in highly sensitized kidney transplant recipients
    Yin Hang
    Wan Hao
    Hu Xiao-peng
    Li Xiao-bei
    Wang Wei
    Liu Hang
    Ren Liang
    Zhang Xiao-dong
    CHINESE MEDICAL JOURNAL, 2011, 124 (13) : 1928 - 1932
  • [24] Endotrophin Levels Are Associated with Allograft Outcomes in Kidney Transplant Recipients
    Sparding, Nadja
    Genovese, Federica
    Rasmussen, Daniel Guldager Kring
    Karsdal, Morten A.
    Krogstrup, Nicoline V.
    Nielsen, Marie Bodilsen
    Hornum, Mads
    Nagarajah, Subagini
    Birn, Henrik
    Jespersen, Bente
    Tepel, Martin
    Norregaard, Rikke
    BIOMOLECULES, 2023, 13 (05)
  • [25] Differential Alloimmune Response in Highly Sensitized and Non-Sensitized Kidney Transplant Recipients
    Negi, Sarita
    Rutman, Alissa
    Paraskevas, Steven
    Tchervenkov, Jean
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 89 - 89
  • [26] Outcomes of Kidney Transplantation in HIV Positive Highly Sensitized Recipients
    Karhadkar, S.
    Panichella, J.
    Resweber, H.
    Nguyen, K.
    Di Carlo, A.
    Karhadkar, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 369 - 369
  • [28] Intravenous Immunoglobulin and Rituximab in HLA Highly Sensitized Kidney Transplant Recipients
    Querido, S.
    Weigert, A.
    Adragao, T.
    Henriques, J.
    Birne, R.
    Matias, P.
    Jorge, C.
    Nascimento, C.
    Bruges, M.
    Machado, D.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (03) : 723 - 727
  • [29] Protein A immunoadsorption combined with rituximab in highly sensitized kidney transplant recipients
    Yin Hang
    Hu Xiao-peng
    Li Xiao-bei
    Liu Hang
    Wang Wei
    Ren Liang
    Wang Yong
    Zhang Xiao-dong
    CHINESE MEDICAL JOURNAL, 2009, 122 (22) : 2752 - 2756
  • [30] Three-Year Outcomes of Highly-Sensitized Kidney Transplant Recipients Desensitized with Imlifidase (IdeS).
    Huang, E.
    Choi, J.
    Vo, A.
    Peng, A.
    Najjar, R.
    Sethi, S.
    Kjellman, C.
    Winstedt, L.
    Ammerman, N.
    Jordan, S. C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 588 - 589